| P50 | author | Anne-Claude Crémieux | Q33295081 |
| P2093 | author name string | F Laurent | |
| | A Saleh-Mghir | |
| | C Perronne | |
| | P Tattevin | |
| | J M Miró | |
| | B Davido | |
| | I Ghout | |
| | L Massias | |
| | C Garcia de la Maria | |
| P2860 | cites work | Generic antibiotic drugs: is effectiveness guaranteed? | Q38000438 |
| | Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus | Q39848923 |
| | Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis. | Q40892298 |
| | Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography | Q41265449 |
| | Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator | Q41890029 |
| | Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus | Q42027484 |
| | Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus | Q54627504 |
| | Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus | Q83583751 |
| | Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model | Q28474000 |
| | Simultaneous inference in general parametric models | Q29619454 |
| | Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease | Q33677550 |
| | Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group | Q33852247 |
| | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children | Q34157657 |
| | Vancomycin | Q34420845 |
| | Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y | Q34426508 |
| | Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu | Q34611253 |
| | Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. | Q34667134 |
| | Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists | Q34910366 |
| | Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis | Q35534742 |
| | Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model | Q35666429 |
| | Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus | Q35685049 |
| | Quality assessment of U.S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays | Q36018817 |
| | Product quality of parenteral vancomycin products in the United States | Q36018909 |
| | Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci | Q36752622 |
| | Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin | Q36870858 |
| | Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. | Q37269872 |
| | Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. | Q37392917 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| | vancomycin | Q424027 |
| | methicillin-resistant Staphylococcus aureus | Q595158 |
| P304 | page(s) | 1157-1162 | |
| P577 | publication date | 2012-12-17 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits | |
| P478 | volume | 57 | |